Axogen (AXGN) Common Equity (2010 - 2026)

Axogen's Common Equity history runs 17 years deep, the most recent figure standing at $244.8 million for Q1 2026.

• In Q1 2026, Common Equity rose 132.34% year-over-year to $244.8 million; the TTM figure through Mar 2026 stood at $244.8 million (up 132.34% YoY), while the FY2025 annual figure was $128.8 million, up 24.0% from the prior year.
• Common Equity was $244.8 million for Q1 2026 at Axogen, up from $128.8 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $244.8 million in Q1 2026 to a low of $93.2 million in Q1 2024.
• Historically, Common Equity has averaged $111.8 million across 5 years, with a median of $101.4 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Common Equity decreased 14.33% in 2022, then soared 132.34% in 2026.
• A 5-year view of Common Equity shows it stood at $101.0 million in 2022, then dropped by 5.28% to $95.7 million in 2023, then advanced by 8.62% to $103.9 million in 2024, then gained by 24.0% to $128.8 million in 2025, then soared by 90.0% to $244.8 million in 2026.
• The last three Common Equity figures came in at $244.8 million (Q1 2026), $128.8 million (Q4 2025), and $120.8 million (Q3 2025), per Business Quant data.